Bernheim Kelley Injury Lawyers Investigating BioZorb Injury Claims & Taking New Clients Nationwide
FORT LAUDERDALE, FL – April 22, 2025 – Bernheim Kelley Injury Lawyers is actively investigating claims related to BioZorb® marker complications and is now accepting new clients. Many patients who received BioZorb markers after breast cancer surgery have reported serious complications, including pain, infection, device migration, and scarring. Patients who suffered injuries from BioZorb markers or had to undergo additional surgeries may have the right to seek compensation and hold Hologic® Inc. accountable through a lawsuit.
BioZorb was created to help doctors target radiation therapy after lumpectomy procedures. Reports indicate that the BioZorb implant’s polylactic acid (PLA) component, designed to dissolve over time, can instead cause inflammation. Additionally, the permanent titanium marker has migrated or eroded through tissue in some cases, causing painful and dangerous complications. It has been found to cause health issues such as rashes, seroma (fluid buildup), chronic discomfort, and more. Many patients have required additional surgeries to remove the device.
It has been alleged that Hologic was aware of the risks associated with delayed resorption and migration but continued to market the device aggressively. The FDA has also cited Hologic for failing to report serious injuries in a timely manner. This raises questions about the company’s accountability and handling of patient safety. Their inaction may have further compounded the harm done to patients.
“This device was marketed as a solution, but for too many patients, it’s become a never-ending nightmare,” said Jesse Bernheim, CEO and Trial Attorney at Bernheim Kelley Injury Lawyers. “Patients deserve answers and accountability—and we’re determined to fight for them.”
BioZorb was recalled in March 2024 after the FDA issued a Class I recall—the most serious type—due to reports of severe injuries. The recall affected over 53,000 devices distributed between April 29, 2019, and April 1, 2024. By the time of the recall, there had been 71 reported injuries linked to BioZorb markers, including pain, infection, device migration, and the need for additional surgery.
Bernheim Kelley Injury Lawyers encourages anyone who has suffered complications from a BioZorb marker to seek legal representation. The firm is now accepting new clients and offering free case evaluations to determine whether patients may have a viable claim for compensation.
“[Patients] trusted this device to help them, not traumatize them further. We’re investigating these cases to hold [Hologic] accountable and help patients regain their dignity and hope.”
If you or a loved one has suffered complications from a BioZorb marker, you may be entitled to compensation. Contact Bernheim Kelley Injury Lawyers today for a free case evaluation and to learn more about your legal options.
About Bernheim Kelley Injury Lawyers
Bernheim Kelley Injury Lawyers is a nationally recognized law firm with decades of experience representing clients in mass tort, product liability, and personal injury cases. Founded by Jesse Bernheim, Esq., the firm has secured over $1 billion in settlements and judgments on behalf of clients nationwide.
Earning recognition for delivering excellent, individualized legal representation, Bernheim Kelley Injury Lawyers is dedicated to protecting the legal rights of those who have suffered harm due to negligence. They believe that Real Justice goes beyond compensation to restore dignity, peace of mind, and confidence in the future for victims and their families.
Contact: David Haut
Chief Marketing Officer
1212 East Broward Blvd, 3rd Floor
Fort Lauderdale, FL 33301
954-866-1111
[email protected]
https://realjustice.com/
Facebook
Instagram
X
LinkedIn
YouTube
###